News Release 2013
-
- November 19, 2013
- Release of Flutiform, a combination drug for asthma treatment
-
- November 5, 2013
- Summary of Consolidated Financial Results (For the Second Quarter Ended September 30, 2013) [Japanese Standard]
-
- October 17, 2013
- Kyorin and Kissei announce the initiation of a Phase I clinical trial of KRP-EPA605/ KEA-0447 for the treatment of overactive bladder
-
- September 20, 2013
- Approval received for Flutiform, a combination drug for asthma treatment
-
- July 30, 2013
- Consolidated Financial Results (For the First Quarter Ended June 30,2013)- Supplementary Information
-
- July 30, 2013
- Summary of Consolidated Financial Results (For the First Quarter Ended June 30,2013)［Japanese Standard］
-
- May 9, 2013
- Summary of Consolidated Financial Results(For the fiscal year ended March 31, 2013)
-
- May 9, 2013
- Financial Results for the Fiscal 2012, the Year Ended March 31, 2013- Supplementary Information
-
- March 25, 2013
- Approval Received for PENTASA® Suppositories 1g,a Drug for Ulcerative colitis.
-
- February 4, 2013
- Consolidated Financial Results (For the Third Quarter Ended December 31,2012)- Supplementary Information
-
- February 4, 2013
- Summary of Consolidated Financial Results (For the Third Quarter Ended December 31,2012)［Japanese Standard］
